Sun, Dec 21, 2014, 2:19 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Allergan Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • foxeelicious foxeelicious Dec 1, 2012 3:15 PM Flag

    Excellent SkinMedica Acqusition

    How did you figure that out? What criteria? Agreed, it is difficult to evaluate at times given pipelines in progress and acquisitions they do from time to time. Fiscal cliff distorts so many things right now.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Even more difficult when it comes to biotech. I use various methodologies such as rigorous DCF valuation, relative valuation and technical and momentum assessment when evaluating stocks. It also has a lot to do with the overall macro outlook of the markets in general. Taxes rising and growth stagnating with many companies forecasting negatively. With a price to sales ratio of near 5... AGN is worth 28.3B and 5.7B in sales. If AGN price to sales slides closer to 4 it is still worth 20B and under $75.00. I don't have anything against the company it just not a good time to be investing.

      Sentiment: Sell

212.63+0.45(+0.21%)Dec 19 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST